ICICI Securities Limited
Nuvama Wealth Management Limited
Jm Financial Limited
Jupiter Life Line Hospitals Limited is among the key multi-specialty tertiary and quaternary healthcare providers in the Mumbai Metropolitan Area (MMR) and western region of India with a total bed capacity of 1,194 hospital beds across three hospitals as of March 31, 2023. It has been operating as a corporate quaternary care healthcare service provider in the western regions of India and currently operates three hospitals under the “Jupiter” brand in Thane, Pune, and Indore.
According to the CRISIL Report, the company’s Thane and Indore hospitals are amongst the few hospitals in the western region of India to provide neuro-rehabilitation services through a dedicated robotic and computer-assisted neuro-rehabilitation center. Additionally, it operates one of the few multi-organ transplant centers in Thane. All the hospitals in Thane, Pune, and Indore have been certified by the National Accreditation Board for Hospitals & Healthcare Providers (NABH) and have been accredited in the field of medical testing by the National Accreditation Board for Testing and Calibration Laboratories (NABL). There are 1,306 doctors including specialists, physicians and surgeons, as of March 31, 2023. It is also currently in the process of developing a multi-specialty hospital in Dombivli, Maharashtra, which is designed to accommodate over 500 beds and has commenced construction in April 2023
The company’s inpatient and outpatient revenue is diversified across hospitals with Thane, Pune, and Indore hospitals accounting for 54.18%, 34.03%, and 11.79%, respectively, of the revenue from operations in Fiscal 2023.
For year/ period ended ( in Cr.)
H1FY23 | FY22 | FY21 | |
---|---|---|---|
Total Revenue | 902.96 | 737.14 | 490.26 |
Profit After Tax | 72.90 | 51.12 | (2.29) |
EPS | 13.95 | 10.05 | (0.45) |
OPM (%) | 14.25% | 10.46% | 0.31% |
PATM (%) | 8.07% | 6.93% | -0.47% |
The Company is a known chain of Hospitals in the MMR regions and gaining preference due to its high-tech and advanced healthcare services with ultramodern diagnostic services. Investors may consider investment for the medium to long term in this issue.
Never Miss IPO Investment